[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @APCCC_Lugano Advanced Prostate Cancer Consensus Conference Advanced Prostate Cancer Consensus Conference posts on X about future, advanced, history, history of the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::2192533356/interactions)  - X Week XXXXX +93% - X Month XXXXXX +130% - X Months XXXXXXX +13% - X Year XXXXXXX +70% ### Mentions: X [#](/creator/twitter::2192533356/posts_active)  - X Year XX +48% ### Followers: XXXXX [#](/creator/twitter::2192533356/followers)  - X Week XXXXX +0.18% - X Month XXXXX +1.60% - X Months XXXXX +8.20% - X Year XXXXX +19% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2192533356/influencer_rank)  ### Social Influence **Social topic influence** [future](/topic/future), [advanced](/topic/advanced), [history](/topic/history), [history of](/topic/history-of) ### Top Social Posts Top posts by engagements in the last XX hours "A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024 (JUST OUT) The APCCC 2024 panel failed to reach consensus on XX% of its XXX questions underscoring substantial evidence gaps in the management of advanced prostate cancer. By mapping these areas of non-consensus to ongoing phase X studies identified on major clinical trial registries the authors highlight how current research efforts may begin to address somebut not allof these uncertainties. While many trials are poised to inform contested clinical" [X Link](https://x.com/APCCC_Lugano/status/1997259736341774777) 2025-12-06T11:00Z 4936 followers, 2924 engagements "Prostate Cancer Risk and DNA Mismatch Repair Deficiency Among Lynch Syndrome Patients Study examines #ProstateCancer (PC) in men with Lynch syndrome (LS) finding that they face a substantially increased riskparticularly carriers of MSH2 EPCAM or MSH6 pathogenic variants and those with a family history of PC. Among XXX LS patients XX developed PC with a XX% cumulative incidence by age XX. Tumors frequently showed mismatch repair deficiency (dMMR) especially in higher-risk cancers and in MSH2/EPCAM carriers while no dMMR tumors appeared in MLH1 or PMS2 carriers. dMMR was strongly linked with" [X Link](https://x.com/APCCC_Lugano/status/1997987662121050116) 2025-12-08T11:12Z 4936 followers, 2888 engagements "Dear Colleagues at #PROSCA25 As we approach #APCCC26 NEXT YEAR we share our Publication from last APCCC Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇 The Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where high-quality evidence is still lacking. The #APCCC26 is planned for NEXT year in Lugano and warmly invite you to attend. The conference gathers expert opinions on controversial clinical issues particularly in advanced prostate cancer offering" [X Link](https://x.com/APCCC_Lugano/status/1996915378153263221) 2025-12-05T12:11Z 4936 followers, 4570 engagements "Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of UrologyYoung Academic Urologists Prostate Cancer Working Group Multi-institutional Study This multicenter retrospective study assessed whether modern PSMA-PET staging improves short-term outcomes compared with conventional imaging in 1475 high-risk prostate cancer patients treated with radical prostatectomy and extended lymph node dissection. After careful matching of baseline" [X Link](https://x.com/APCCC_Lugano/status/1998327391807057990) 2025-12-09T09:42Z 4936 followers, 1351 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@APCCC_Lugano Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference posts on X about future, advanced, history, history of the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX +93%
- X Month XXXXXX +130%
- X Months XXXXXXX +13%
- X Year XXXXXXX +70%
Mentions: X #
- X Year XX +48%
Followers: XXXXX #
- X Week XXXXX +0.18%
- X Month XXXXX +1.60%
- X Months XXXXX +8.20%
- X Year XXXXX +19%
CreatorRank: XXXXXXXXX #
Social Influence
Social topic influence future, advanced, history, history of
Top Social Posts
Top posts by engagements in the last XX hours
"A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024 (JUST OUT) The APCCC 2024 panel failed to reach consensus on XX% of its XXX questions underscoring substantial evidence gaps in the management of advanced prostate cancer. By mapping these areas of non-consensus to ongoing phase X studies identified on major clinical trial registries the authors highlight how current research efforts may begin to address somebut not allof these uncertainties. While many trials are poised to inform contested clinical"
X Link 2025-12-06T11:00Z 4936 followers, 2924 engagements
"Prostate Cancer Risk and DNA Mismatch Repair Deficiency Among Lynch Syndrome Patients Study examines #ProstateCancer (PC) in men with Lynch syndrome (LS) finding that they face a substantially increased riskparticularly carriers of MSH2 EPCAM or MSH6 pathogenic variants and those with a family history of PC. Among XXX LS patients XX developed PC with a XX% cumulative incidence by age XX. Tumors frequently showed mismatch repair deficiency (dMMR) especially in higher-risk cancers and in MSH2/EPCAM carriers while no dMMR tumors appeared in MLH1 or PMS2 carriers. dMMR was strongly linked with"
X Link 2025-12-08T11:12Z 4936 followers, 2888 engagements
"Dear Colleagues at #PROSCA25 As we approach #APCCC26 NEXT YEAR we share our Publication from last APCCC Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇 The Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where high-quality evidence is still lacking. The #APCCC26 is planned for NEXT year in Lugano and warmly invite you to attend. The conference gathers expert opinions on controversial clinical issues particularly in advanced prostate cancer offering"
X Link 2025-12-05T12:11Z 4936 followers, 4570 engagements
"Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of UrologyYoung Academic Urologists Prostate Cancer Working Group Multi-institutional Study This multicenter retrospective study assessed whether modern PSMA-PET staging improves short-term outcomes compared with conventional imaging in 1475 high-risk prostate cancer patients treated with radical prostatectomy and extended lymph node dissection. After careful matching of baseline"
X Link 2025-12-09T09:42Z 4936 followers, 1351 engagements